These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 18884800)
1. BAL in the treatment of massive overdosage with mapharsen. ARMSTRONG CD; FLEMING WJ; THALMANN WG Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18884800 [No Abstract] [Full Text] [Related]
2. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL. EAGLE H; MAGNUSON HJ; FLEISCHMAN R J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620 [No Abstract] [Full Text] [Related]
3. BAL in the treatment of arsenic ingestion of children. WOODY NC; KOMETANI JT Pediatrics; 1948 Mar; 1(3):372-8. PubMed ID: 18908858 [No Abstract] [Full Text] [Related]
4. The systemic treatment of arsenic poisoning with BAL (2,3-dimercaptopropanol). EAGLE H J Vener Dis Inf; 1946 May; 27():114-21. PubMed ID: 21028660 [No Abstract] [Full Text] [Related]
5. A case of arsenic encephalopathy successfully treated with BAL. MASTERS JB J Indiana State Med Assoc; 1948 Dec; 41(12):1254-6. PubMed ID: 18892437 [No Abstract] [Full Text] [Related]
6. Treatment of arsenical reaction with BAL. PROSSER-THOMAS EW Med Press; 1948 Apr; 219(17):379. PubMed ID: 18913066 [No Abstract] [Full Text] [Related]
7. A case of arsenical dermatitis treated with BAL. GRAY JJ J Med Assoc Eire; 1948 Sep; 23(135):38. PubMed ID: 18881498 [No Abstract] [Full Text] [Related]
8. [On a new antidote against arsenic and heavy metal poisoning, it BAL]. RAVENNA F Farmaco Sci Tec; 1947; 2(6):574-8. PubMed ID: 18913616 [No Abstract] [Full Text] [Related]
9. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication. LUETSCHER JA; EAGLE H; LONG-COPE WT J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627 [No Abstract] [Full Text] [Related]
10. [EI BAL in the treatment of poisoning by arsenical and auric preparations]. BERMUDEZ ABREU VP Bol Soc Cubana Dermatol Sifilogr; 1949 Jun; 6(2):45-62. PubMed ID: 18134646 [No Abstract] [Full Text] [Related]
11. OX-217 (B.A.L.) as an antidote in complication of arsenic therapy. SRIVASTAVA SC Clin Soc J; 1947 Nov; 11(2-3):48. PubMed ID: 18916140 [No Abstract] [Full Text] [Related]
12. [A case of arsical thrombocytopenic purpura treated with BAL]. DE CORDOVA CASTRO A; PENALVER BALLINA R Bol Soc Cubana Dermatol Sifilogr; 1948 Mar; 5(1):13-7. PubMed ID: 18856541 [No Abstract] [Full Text] [Related]
13. The effect of BAL on experimental lead, tungsten, vanadium, uranium, copper and copper-arsenic poisoning. LUSKY LM; BRAUN HA; LAUG EP J Ind Hyg Toxicol; 1949 Sep; 31(5):301-5. PubMed ID: 18141688 [No Abstract] [Full Text] [Related]
14. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats. RIKER WF; ROSENFELD G J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115 [No Abstract] [Full Text] [Related]
15. [Biochemical injury in arsenical intoxication and the British Anti-Lewisite]. PETERS RA Rev Med Liege; 1948 Dec; 3(23):687-98. PubMed ID: 18100780 [No Abstract] [Full Text] [Related]
16. [Action of dimercapto-2-3-propanol in some arsenic poisonings]. DELGA J Ann Pharm Fr; 1950 Feb; 8(2):106-10. PubMed ID: 15413841 [No Abstract] [Full Text] [Related]
17. Massive arsenic poisoning--effect of hemodialysis and dimercaprol on arsenic kinetics. Mathieu D; Mathieu-Nolf M; Germain-Alonso M; Neviere R; Furon D; Wattel F Intensive Care Med; 1992; 18(1):47-50. PubMed ID: 1578049 [TBL] [Abstract][Full Text] [Related]
18. Use of BAL in the treatment of arsenical neuropathy. MALHOTRA SL Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288 [No Abstract] [Full Text] [Related]
19. Time relationships in the reversal by BAL of the chemotherapeutic effect of mapharsen. PFEIFFER CC; JENNEY EH; ROSS CA Fed Proc; 1947; 6(1):363. PubMed ID: 20249608 [No Abstract] [Full Text] [Related]
20. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management. CORMIA FE; BLAUNER SG Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293 [No Abstract] [Full Text] [Related] [Next] [New Search]